Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.49 0.00(0.00%) 4:00PM EDT
Prev Close:1.49
Open:1.51
Bid:1.46 x 100
Ask:1.54 x 100
1y Target Est:5.00
Beta:2.49355
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:1.47 - 1.55
52wk Range:1.19 - 4.42
Volume:385,333
Avg Vol (3m):1,000,700
Market Cap:180.76M
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRA 0.00%180.76M
PFEUp 0.52%209.90B
DVAX 0.00%610.16M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):355.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.45
Quarterly EPS Est (Jun-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback